Antiangiogenic cytokines as potential new therapeutic targets for resveratrol in diabetic retinopathy
Mihaela Popescu,1 Cătălina Bogdan,2 Adela Pintea,3 Dumitriţa Rugină,3 Corina Ionescu1 1Department of Biochemistry, University of Medicine and Pharmacy “Iuliu Haţieganu”, Cluj-Napoca, Romania; 2Department of Dermopharmacy and Cosmetics, University of Medicine and Pharmacy “Iuliu Haţieganu”, Cluj-Napo...
Saved in:
Main Authors: | Popescu M (Author), Bogdan C (Author), Pintea A (Author), Rugină D (Author), Ionescu C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resveratrol: Its Path from Isolation to Therapeutic Action in Eye Diseases
by: Roxana Pop, et al.
Published: (2022) -
Exploration of Oxygen-Induced Retinopathy Model to Discover New Therapeutic Drug Targets in Retinopathies
by: Maria Vähätupa, et al.
Published: (2020) -
Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach
by: Paola Orlandi, et al.
Published: (2021) -
Glyoxalase System as a Therapeutic Target against Diabetic Retinopathy
by: Gemma Aragonès, et al.
Published: (2020) -
Mechanism and therapeutic targets of circulating immune cells in diabetic retinopathy
by: Bowen Zhao, et al.
Published: (2024)